|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
The Board of Directors has previously resolved, with its resolution dated 25 April 2022, that Ms. Nursel İlgen, Investor Relations Coordinator and Ms. Nevin İmamoğlu İpek, Finance Coordinator Responsible for Compliance with Securities Regulations, both under the management of Mr. Polat Şen, CFO, carry out the duties described in Article 11 of the Capital Markets Board Communiqué II-17.1 on Corporate Governance Principles. As of 31 January 2025, Ms. Nursel İlgen will leave her duty due to retirement. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||